• Latest
  • Trending
Ultragenyx (RARE) Stock Pops 13% as FDA Approves a First-of-Its-Kind Gene Therapy

Ultragenyx (RARE) Stock Pops 13% as FDA Approves a First-of-Its-Kind Gene Therapy

September 18, 2026
Hackers Hit Ledger and 177 Other Brands With a Crypto Address-Swapping Attack

Hackers Hit Ledger and 177 Other Brands With a Crypto Address-Swapping Attack

November 17, 2026
Circle Expands Disparte and Walia Leadership Roles

Circle Expands Disparte and Walia Leadership Roles

November 17, 2026
Sui Price Holds Key Support as Stablecoin Supply Climbs to $552 Million

Sui Price Holds Key Support as Stablecoin Supply Climbs to $552 Million

November 17, 2026
Ex-Robinhood Engineer Pleads Guilty to $125K Crypto Trading Fraud

Ex-Robinhood Engineer Pleads Guilty to $125K Crypto Trading Fraud

November 17, 2026
CFTC Makes Historic Move With Blockchain Derivatives Approval

CFTC Makes Historic Move With Blockchain Derivatives Approval

November 17, 2026
Summit Therapeutics (SMMT) Stock Drops After FDA Rejects Lung Cancer Drug Application

Summit Therapeutics (SMMT) Stock Drops After FDA Rejects Lung Cancer Drug Application

November 17, 2026
Meta Has Staff Testing a Cashless Prediction Market App: WSJ

Meta Has Staff Testing a Cashless Prediction Market App: WSJ

November 17, 2026
Figment to Support Staking on BNY’s Custody Platform

Figment to Support Staking on BNY’s Custody Platform

November 17, 2026
AMD Stock Slips Premarket as Huang Exit Rattles Chip Sector

AMD Stock Slips Premarket as Huang Exit Rattles Chip Sector

November 16, 2026
  • Privacy Policy
Tuesday, November 17, 2026
MtRushmoreCrypto - Where Crypto Rocks
  • Home
  • Top News
  • Crypto
  • Crypto Technical Analysis
  • About Us
No Result
View All Result
  • Home
  • Top News
  • Crypto
  • Crypto Technical Analysis
  • About Us
No Result
View All Result
Logo
No Result
View All Result
Home Crypto Technical Analysis

Ultragenyx (RARE) Stock Pops 13% as FDA Approves a First-of-Its-Kind Gene Therapy

J_News by J_News
September 18, 2026
in Crypto Technical Analysis, Top News
0
Ultragenyx (RARE) Stock Pops 13% as FDA Approves a First-of-Its-Kind Gene Therapy
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter


Follow on Google News

TLDR

  • The FDA approved Ultragenyx’s Fayuvi, the first-ever treatment targeting the root cause of Sanfilippo syndrome Type A
  • Ultragenyx (RARE) stock closed up 13% to $14.50 on Thursday following the announcement
  • Fayuvi is a one-time gene therapy administered through a single infusion, using a modified virus to reach the brain
  • Clinical trial data showed children who received the therapy scored 23.5 points higher on cognitive tests than untreated patients
  • This is Ultragenyx’s second gene therapy approval and sixth FDA approval overall

Ultragenyx (RARE) stock closed up 13% to $14.50 on Thursday after the FDA approved Fayuvi, a gene therapy for Sanfilippo syndrome Type A, a rare inherited disease that progressively destroys the brain and nervous system in children.


RARE Stock Card
Ultragenyx Pharmaceutical Inc., RARE

Before this approval, there was no treatment available that could address the root cause of the disease. Doctors could only manage individual symptoms.

Fayuvi works by correcting a sulfamidase enzyme deficiency. Without this enzyme, a complex sugar molecule called heparan sulfate builds up in the brain, causing progressive cell damage and neurodegeneration.

The therapy is given just once, through a standard infusion into the bloodstream. It uses AAV9, a harmless modified virus, to cross from the blood into the brain and central nervous system.

The FDA based its approval on up to eight years of clinical trial data. Children who received Fayuvi scored 23.5 points higher on cognitive tests compared to untreated patients.

Researchers also tracked heparan sulfate levels directly in brain fluid. The therapy continuously cleared the toxic buildup over time in treated patients.


Betpanda


FDA Approval and Availability

Fayuvi will only be available at Qualified Treatment Centers, which are specialized hospitals trained to administer gene therapies. Ultragenyx plans to launch a website within days listing authorized locations.

Related articles

Hackers Hit Ledger and 177 Other Brands With a Crypto Address-Swapping Attack

Hackers Hit Ledger and 177 Other Brands With a Crypto Address-Swapping Attack

November 17, 2026
Circle Expands Disparte and Walia Leadership Roles

Circle Expands Disparte and Walia Leadership Roles

November 17, 2026

The company expects to ship Fayuvi to those centers within 30 to 60 days. Ultragenyx estimates around 3,000 to 5,000 children in accessible regions are living with Sanfilippo syndrome Type A.

The average life expectancy for untreated patients is around 15 years. That number underscores just how much this approval matters for affected families.

Manufacturing and Scale

Fayuvi is manufactured at two specialized facilities, one in Massachusetts and one in Ohio. The dual-site setup is intended to support consistent supply of the therapy going forward.

This approval marks Ultragenyx’s second gene therapy to reach patients and its sixth FDA approval overall. The company has been building out its rare disease pipeline over several years.

The FDA granted the approval based on its review of the clinical data, with scientists tracking both cognitive performance and biological markers in trial participants.

Ultragenyx did not immediately announce a price for Fayuvi, though gene therapies in this class have historically carried high list prices due to their one-time administration and manufacturing complexity.

The therapy became available for ordering through Qualified Treatment Centers following the approval announcement on Thursday.


Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.

Sign up today and get 50% OFF full access to our premium stock picks.

Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.



Source link

ShareTweetShareShare

Related Posts

Hackers Hit Ledger and 177 Other Brands With a Crypto Address-Swapping Attack

Hackers Hit Ledger and 177 Other Brands With a Crypto Address-Swapping Attack

by J_News
November 17, 2026
0

Key TakeawaysReport URI found malware in 188 Optimizely snippets across 178 brands, including Ledger, Zoom and HSBC.The code swapped copied...

Circle Expands Disparte and Walia Leadership Roles

Circle Expands Disparte and Walia Leadership Roles

by J_News
November 17, 2026
0

TL;DR Dante Disparte becomes vice chairman for strategy and global affairs. Mandeep Walia adds chief operating officer to his compliance...

Sui Price Holds Key Support as Stablecoin Supply Climbs to $552 Million

Sui Price Holds Key Support as Stablecoin Supply Climbs to $552 Million

by J_News
November 17, 2026
0

TLDR Sui (SUI) traded near $0.7231 on November 17, up 0.50% and about 43% below its September high. The token...

Ex-Robinhood Engineer Pleads Guilty to $125K Crypto Trading Fraud

Ex-Robinhood Engineer Pleads Guilty to $125K Crypto Trading Fraud

by J_News
November 17, 2026
0

Former Robinhood software engineer Huaisong “Jerry” Xiang has pleaded guilty to wire fraud after using confidential information about upcoming crypto...

CFTC Makes Historic Move With Blockchain Derivatives Approval

CFTC Makes Historic Move With Blockchain Derivatives Approval

by J_News
November 17, 2026
0

The U.S. Commodity Futures Trading Commission (CFTC) has opened historic doors for blockchain technology adoption in traditional financial markets as it...

Load More

Enter your email address:

Delivered by FeedBurner

Quick Navigate

  • Home
  • Crypto
  • Crypto Technical Analysis
  • Top News
  • Thank You
  • Store
  • About Us

Top News

Gram Price: Jumps 9% as Telegram Opens Money Wallet to More Users

Best Perp DEXes in 2026: Hyperliquid, Aster, Lighter, edgeX, and ApeX Omni Compared

Why Does Ethereum Gas Estimation Fail?

© 2021 mtrushmorecrypto - Crypto Related News Blog

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
No Result
View All Result
  • Home
  • Top News
  • Crypto
  • Crypto Technical Analysis
  • About Us

© 2021 mtrushmorecrypto - Crypto Related News Blog